Last Updated:
Access Report
Name Designation Appointment Date Status
Yogesh Subhash Balpelwad

Appointed as Designated Partner since December 2021

 Designated Partner 31-Dec-2021 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Subhash Divanji Balpelwad

Appointed as Designated Partner since December 2021

 Designated Partner 31-Dec-2021 Current

People Timeline

Explore the timeline of key personnel in Cliniasia Clinical Research Services Llp's leadership journey.

Contact Details
  • Address Gut No. 101, Flat No. 013, Deluxe Palms Devlai, Aurangabad Maharashtra, 431007, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 431007
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Cliniasia Clinical Research Services Llp?
You can contact Cliniasia Clinical Research Services Llp through their registered address at Gut No. 101, Flat No. 013, Deluxe Palms Devlai, Aurangabad Maharashtra, 431007, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Cliniasia Clinical Research Services Llp?
The current directors of Cliniasia Clinical Research Services Llp are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • YOGESH SUBHASH BALPELWAD
  • SUBHASH DIVANJI BALPELWAD
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available